Breast Cancer Research
Leading citation impact metric from Clarivate Journal Citation Reports
126 papers with at least that number of citations each
State Council for Professorship (HĐGSNN) Scoring
Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)
HĐGSNN Score History
By article publication year| Year | Max Score | Evaluation Details | Source |
|---|---|---|---|
| 2026 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 6.2) | 🔵 Computed |
| 2025 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 5.6) | 🔵 Computed |
| 2023 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 7.4) | 🔵 Computed |
| 2021 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 6.466) | 🔵 Computed |
| 2019 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 5.676) | 🔵 Computed |
| 2018 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 6.142) | 🔵 Computed |
Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.
Aims & Scope
Breast Cancer Research is an international, peer-reviewed online journal, publishing original research, reviews, editorials and reports. Open access research articles of exceptional interest are published in all areas of biology and medicine relevant to breast cancer, including normal mammary gland biology, with special emphasis on the genetic, biochemical, and cellular basis of breast cancer. In addition to basic research, the journal publishes preclinical, translational and clinical studies with a biological basis, including Phase I and Phase II trials.
SCImago & Scopus Journal Intelligence
Not indexed in SCImago / Scopus databaseThis journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
| Category | Index | Rank | Quartile |
|---|---|---|---|
ONCOLOGY | JCRSCIE | 60/333 | Q1 |
ONCOLOGY | JCISCIE | 59/333 | Q1 |
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
| Year | Impact Factor | Articles / Year | Total Citations |
|---|---|---|---|
| 2026 | — | 187 | 58 |
| 2025 | 5.6 | 249 | 1,119 |
| 2024 | — | 193 | 2,371 |
| 2023 | 7.4 | 155 | 3,105 |
| 2022 | — | 101 | 2,741 |
| 2021 | 6.466 | 120 | 4,341 |
| 2020 | — | 138 | 8,964 |
| 2019 | 5.676 | 157 | 9,408 |
| 2018 | 6.142 | 156 | 7,902 |
| 2017 | — | 135 | 8,828 |
| 2016 | — | 132 | 10,409 |
| 2015 | — | 200 | 12,040 |
Journal Metrics & Citation Visualizations
Impact Factor Trend (2018–2024)
Clarivate IF trend for Breast Cancer Research
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics